Editorial
Published on 01 Jul 2025
Editorial: Pharmacogenomics for improving drug safety and efficacy in cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1649258
- 136 views
Type at least 3 characters
603 articles
Editorial
Accepted on 27 Jun 2025
Editorial: Post-Translational Modifications (PTMs) in Human Cancer: Pharmacological Insights and Therapeutic Opportunities
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654659
Original Research
Accepted on 27 Jun 2025
Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1614753
- 103 views
Systematic Review
Accepted on 20 Jun 2025
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 Genes: Implications for Calcineurin Inhibitors Therapy in Hematopoietic Cell Transplantation Recipients-A Systematic Review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1569353
- 170 views
Original Research
Accepted on 19 Jun 2025
Exploring Biomarkers for Noise-Induced Hearing Loss through Mitochondrial DNA Methylation Analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561791
- 463 views
Systematic Review
Published on 19 Jun 2025
CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572886
- 580 views
Systematic Review
Accepted on 14 Jun 2025
Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: A systematic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1568320
- 347 views
Review
Accepted on 13 Jun 2025
Global Variation in Antibiotic Prescribing Guidelines and the implications for decreasing AMR in the future
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1600787
- 209 views
Original Research
Published on 13 Jun 2025
Hsa_circ_0002238 promotes the malignant behavior of colorectal cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1541820
- 352 views
Original Research
Published on 04 Jun 2025
Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604473
- 1,111 views
Original Research
Published on 03 Jun 2025
Exosomal miR-24-3p mediates myoblast-macrophage crosstalk to promote abdominal muscle repair
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604776
- 743 views
Brief Research Report
Published on 23 May 2025
Dynamic star allele definitions in Pharmacogenomics: impact on diplotype calls, Phenotype predictions and statin therapy recommendations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1584658
- 902 views
Original Research
Published on 22 May 2025
Biological and prognostic insights into the prostaglandin D2 signaling axis in lung adenocarcinoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1562261
- 1,459 views
Brief Research Report
Published on 22 May 2025
Implementation and integration of a multidisciplinary pharmacogenomics service in an underserved integrated behavioral health clinic
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594032
- 907 views
Case Report
Published on 21 May 2025
The role of endoplasmic reticulum aminopeptidase ERAP2 pathogenic mutation rs1363907 in amoxicillin clavulanate-induced liver injury: a special case report
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564124
- 916 views
Original Research
Published on 20 May 2025
ARID1A deficiency attenuates the response to EGFR-TKI treatment in lung adenocarcinoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1582005
- 882 views